Ayma Therapeutics Inc.
  • Home
  • Indications
    • Cardiovascular
    • COVID-19
  • Team
  • Publications
  • Contact Us
  • More
    • Home
    • Indications
      • Cardiovascular
      • COVID-19
    • Team
    • Publications
    • Contact Us

Ayma Therapeutics Inc.

  • Home
  • Indications
  • Team
  • Publications
  • Contact Us

Facts and Figures

Cholesterol 


Heart Disease

Publications

Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis

Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA

Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue


Copyright © 2020 Ayma Therapeutics Inc. - All Rights Reserved.